Funding Portfolio
DCTD supports research across the entire spectrum of areas related to diagnostic and therapeutic approaches to cancer. The graph below depicts the distribution of the $1.44 billion in fiscal year 2024 grant funding managed by DCTD across the Programs and Offices with grant portfolios (the Biometric Research Program does not manage grants). The Developmental Therapeutics Program (DTP) had the largest number of awarded grants, totaling $499 million, followed by the Cancer Imaging Program (CIP) at $336 million.
The distribution of grants across the various programmatic areas is representative of DCTD’s commitment to empowering innovative and cross-functional research to improve diagnostic approaches and facilitate the discovery, development, and effective administration of new treatments for patients diagnosed with cancer.
Distribution of DCTD FY2024 Grant Funding Across Programs ($ in millions)